Par Drugs & Chemicals Overview
Fundamentals of Par Drugs & Chemicals
|P/E Ratio (TTM)||NA|
|Debt to Equity||NA|
Financials of Par Drugs & Chemicals
Financials data is not available for Par Drugs & Chemicals. Please visit after some time.
About Par Drugs & Chemicals
Par Drugs and Chemicals Limited was originally incorporated as a private limited company with the name 'Par Drugs and Chemicals Private Limited' at Bhavnagar, Gujarat. On 26 February 1999. Subsequentl ... y, the company was converted into a public limited company pursuant to special resolution passed by the members in extra-ordinary general meeting of the company held on October 24, 2018 and the name of the company was changed to 'Par Drugs and Chemicals Limited' on 5 November 2018. Vallabhbhai Savani and Sarita Savani were initial subscribers to the Memorandum of Association of the company. The Promoters of the company are Jignesh Vallabhbhai Savani and Falgun Vallabhbhai Savani. The Jignesh Vallabhbhai Savani and Falgun Vallabhbhai Savani have first shares on 19, 2006 through allotment of shares by company. The Company is engaged in the development and manufacture of Active Pharma ingredients ('APIs') for the domestic market as well as for exports to international markets. APIs, also known as 'bulk drugs' or 'bulk actives' are the principal ingredients used in making finished dosages in the form of capsules, tablets, liquid, or other forms of dosage, with the addition of other APIs or inactive ingredients. The Company produce various range of Antacid Molecules which are available in the market and are in great demand. The Company currently own and operate two manufacturing facilities at Bhavnagar and Ankleshwar in the Gujarat. It currently have three manufacturing blocks at Bhavnagar facility for different products. The Bhavnagar facility certified by food & drugs control administration. During the year 2011, the company has added two manufacturing block out of three at Chitra, Bhavnagar facility. One is dedicated facility for its main API and another one is for Fine Chemicals. The Product portfolio presently comprises 12 APIs and 6 Fine Chemicals which are marketed domestically and exported. The Company supplies its products to approximately 16 countries, including both direct and indirect exports. The Key customers include Essential Drugs Company Limited, Taurus Chemicals (P) Limited, Pfizer Limited, United Phosphorus Limited(Samba Jammu Unit), Shiv Silica Private Limited. Read More
|Stocks||Market Cap (cr)||Market Price (₹)||52 Week Low-High (₹)|
|Supriya Lifescience Ltd||₹2,264.38||
|276 - 283.25|
|Celestial Biolabs Ltd||₹4.56||
|1.75 - 1.8|
|JFL Life Sciences Ltd||₹52.24||
|45.1 - 46.05|
|Procter & Gamble Health Ltd||₹8,177.41||
|4851.5 - 4954.3|
|Veerhealth Care Ltd||₹41.24||
|26 - 26|
What is the Share price of Par Drugs & Chemicals (PAR)?
Can I buy Par Drugs & Chemicals (PAR) shares?
How do I buy Par Drugs & Chemicals (PAR) from Angel One?
- Direct investment: You can buy Par Drugs & Chemicals (PAR) shares by opening a Demat account with Angel One.
- Indirect investment: The indirect method involves investing through ETFs and Mutual Funds that offer exposure to Par Drugs & Chemicals (PAR) shares.